Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics

Daniel X Hammer1, Anant Agrawal2, Ricardo Villanueva3

  • 1Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Radiological Devices, Food and Drug Administration, Silver Spring, MD 20993; daniel.hammer@fda.hhs.gov zhuolin.liu@fda.hhs.gov.

Insights

Researchers visualized live human retinal macrophage cells using adaptive optics-optical coherence tomography. These cells show distinct age-related changes and play a role in glaucoma, offering new insights into neuro-ophthalmology.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Immunology

Background:

  • Microglia, the brain's immune cells, are crucial in neural injury response.
  • Previous studies relied on animal models, limiting direct human immune function insights.
  • Retinal microglia, located above the inner limiting membrane (ILM), are accessible for in vivo study.

Purpose of the Study:

  • To characterize live human retinal macrophage (ILM cell) distribution, aging, and dynamics.
  • To investigate the role of these cells in healthy and glaucomatous human eyes.
  • To establish a non-invasive method for visualizing retinal immune cells.

Main Methods:

  • Utilized adaptive optics-optical coherence tomography (AO-OCT) for in vivo imaging of human retinal macrophage cells.
  • Examined both healthy and glaucomatous human eyes.
  • Analyzed cell distribution patterns, density changes with age, and regional involvement in disease.

Main Results:

  • Human ILM macrophage distribution is macular, sparse centrally and peripheral in healthy eyes.
  • ILM macrophage density declines with age at approximately 2% per year.
  • In glaucoma, these cells show early, region-specific nerve fiber layer phagocytosis.

Conclusions:

  • Human retinal macrophage characteristics differ from animal microglia models.
  • AO-OCT enables label-free visualization of live human retinal immune cells.
  • This technique may reveal novel biomarkers for ophthalmologic and neurologic diseases.

Related Concept Videos